{
    "clinical_study": {
        "@rank": "127649", 
        "arm_group": [
            {
                "arm_group_label": "Coolprep", 
                "description": "A total of 2L A : NaCl 5.382g KCl 2.03g Sodium sulfate 15g Polyethylene glycol 3350 200.0g B : Ascorbic acid 9.4g Sodium ascorbate 11.8g"
            }, 
            {
                "arm_group_label": "Picolyte", 
                "description": "Sodium picosulfate 30.0mg Magnesium citrate 10.5g + 36.0g"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators will compare with PEG+ascorbic acid and picosulfate+magnesium citrate\n      about bowel preparation, patient's satisfaction, side effects to identify effectiveness of\n      new bowel preparation drug."
        }, 
        "brief_title": "Comparison Between Coolprep and Picolyte for Bowel Cleansing", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Stasis; Colon", 
        "detailed_description": {
            "textblock": "The investigators can find easily colon cancer and poly by colonoscopy, but bowel\n      preparation is very important to find the lesion. Desirable bowel preparation drug must be\n      clearly removed stool, effective on colonoscopic finding and pathologic finding, quickly\n      administrated agent and eliminated stool, comfort for patient, and less side effects.\n\n      PEG is very safe osmotic laxative. New agent(coolprep) which add ascorbic acid is less salty\n      and less volume. Picosulfate+magnesium citrate(picolyte) taste orange, can be easily\n      prepared bowel for colonoscopy by good taste and small volume. Magnesium with citrate acts\n      like osmotic agent, picosulfate acts irritant agent.\n\n      The investigators will compare with PEG+ascorbic acid and picosulfate+magnesium citrate\n      about bowel preparation, patient's satisfaction, side effects to identify effectiveness of\n      new bowel preparation drug."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age : over 19 years\n\n          -  Who will be done colonoscopy\n\n          -  Who accepted informed consent\n\n        Exclusion Criteria:\n\n          -  Age : over 80 years\n\n          -  Electrolyte imbalance\n\n          -  Liver function test abnormality, ascites(over 2 times, >Child class B)\n\n          -  ARF or CRF(GFS<30)\n\n          -  Recent MI(< 6months) or Unstable angina pectoris\n\n          -  Congestive heart failure(NYHA > 2)\n\n          -  Inflammatory bowel disease\n\n          -  Abdominal minor surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "19 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "This study will include a total of 250 patients. All patient randomized PEG+ascorbica\n        acid(coolprep) and picosulfate magnesium citrate(picolyte), each group will include 125\n        patients.\n\n        The investigators decided sample size to 200 patients after comparing Ottawa scale. The\n        investigators assumed there would be defference about 20 percent of bowel preparation\n        between them. Recently, Ottawa scale of bowel preparation reported about 5 points. The\n        investigators assumed that there could be differences between them about 1 point.  The\n        investigators decided each groups per 100 patients, if significance level was 0.05 and\n        test power is 80 percent. The investigators start this study with a total of 220 patients\n        because 10 percent of 200 patients could be drop out. The investigators readjust about 30\n        patients after interim analysis."
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01774175", 
            "org_study_id": "COOLPREPICOLYTE"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Ascorbic Acid", 
                "Picosulfate sodium", 
                "Magnesium citrate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Bowel preparation", 
            "PEG with ascorbic acid", 
            "Picosulfate"
        ], 
        "lastchanged_date": "January 23, 2013", 
        "number_of_groups": "2", 
        "official_title": "A Randomised Controlled Trial of a 2 Litre Polyethylene Glycol Solution + Ascorbic Acid Versus Sodium Picosulphate + Magnesium Citrate Solution for Bowel Cleansing Prior to Colonoscopy", 
        "overall_official": {
            "affiliation": "Gachon University Gil Medical School", 
            "last_name": "Jun Won Chung, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "* Ottawa scale\nIndividual evaluation of right, mid, and left colon:\nNo liquid - 0 Minimal liquid, no suctioning required - 1 Suction required to see mucosa - 2 Wash and suction - 3 Solid stool,not washable - 4\nEvaluation of the entire colon:\nOverall quantity of fluid 0-2 minimal -0 moderate - 1 Large - 2\n* Aronchick score scale Minimal liquid, visible more than 95% of colon mucosa - excellent Clear liquid covered 5~25% of mucosa, visible more than 90% of colon mucosa - good Solid stool, washable, visible more than 90% of colon mucosa - Fair Solid stool, not washable, visible less than 90% of colon mucosa not washable - Poor Bowel preparation is needed - Inadequate", 
            "measure": "Ottawa scale", 
            "safety_issue": "No", 
            "time_frame": "Ottawa scale will be checked at the end of the colonoscopy. Participants won't be followed up because of this study."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01774175"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gachon University Gil Medical Center", 
            "investigator_full_name": "Chung Jun Won", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Taste, Comfort", 
                "measure": "Patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "Questionnaires related with satisfaction and side effects will be written just befor colonoscopy. Participants won't be followed up because of this study."
            }, 
            {
                "description": "Nausea, Vomiting, Abdominal discomfort, Abdominal distension, Headache, Dizziness, Numbness", 
                "measure": "Symptoms related with bowel preparation", 
                "safety_issue": "No", 
                "time_frame": "Questionnaires related with side effects will be written just befor colonoscopy. Participants won't be followed up because of this study."
            }
        ], 
        "source": "Gachon University Gil Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gachon University Gil Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}